Ignite Creation Date:
2024-05-05 @ 11:49 AM
Last Modification Date:
2024-10-26 @ 9:14 AM
Study NCT ID:
NCT00144807
Status:
COMPLETED
Last Update Posted:
2015-09-02
First Post:
2005-09-02
Brief Title:
ACVBP Plus Rituximab in Patients Aged From 18 to 59 Years With High-risk Diffuse Large B-cell Lymphoma
Sponsor:
Lymphoma Study Association
Organization:
Lymphoma Study Association
Organization Data
Organization:
Lymphoma Study Association
Class:
OTHER
Study ID:
LNH03-3B
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lymphoma Study Association
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None